- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GILD
Recent news which mentions GILD
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
From Benzinga
The Top Healthcare Stocks to Buy With $100
December 01, 2022
From Motley Fool
These 3 Stocks Are Rallying While the Rest of the Market Plunges
November 30, 2022
From Motley Fool
Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures
November 28, 2022
From Benzinga
VALQ Offers Quality-Focused Value Approach
November 22, 2022
From ETF Trends
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
November 22, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
From Benzinga
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
November 20, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
From Benzinga
From Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
November 14, 2022
From Benzinga
2 Top Biotech Stocks to Buy in November
November 12, 2022
From Motley Fool
Novavax stock rallies, even as company offers a dimmer sales forecast for vaccines
November 08, 2022
From MarketWatch
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
November 08, 2022
Tickers
GILD
From Benzinga
Why Shares of Gilead Sciences Rose 27.20% in October
November 08, 2022
Tickers
GILD
From Motley Fool
US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead
November 07, 2022
From Benzinga
3 No-Brainer Dividend Stocks to Buy in November
November 05, 2022
From Motley Fool
G1 Therapeutics Says Its Lead Candidate May Cut Adverse Events Of Gilead's Breast Cancer Drug
November 02, 2022
From Benzinga
9 Health Care Stocks Whale Activity In Today's Session
November 01, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.